Literature DB >> 12695161

Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis.

E Selvi1, S A Tripodi, M Catenaccio, S Lorenzini, D Chindamo, S Manganelli, R Romagnoli, F Ietta, L Paulesu, C Miracco, M Cintorino, R Marcolongo.   

Abstract

OBJECTIVE: To evaluate whether, in patients with the diffuse form of systemic sclerosis (dSSc), macrophage migration inhibitory factor (MIF) production is dysregulated.
METHODS: 10 patients with dSSc and 10 healthy controls, matched for age and sex, were studied. MIF expression was evaluated by immunohistochemistry on formalin fixed skin biopsies of patients with dSSc and controls. MIF levels were assayed in the sera and in the supernatants of skin cultured fibroblasts by a colorimetric sandwich enzyme linked immunosorbent assay (ELISA). MIF concentrations in culture medium samples and in serum samples were compared by Student's two tailed t test for unpaired data.
RESULTS: Anti-MIF antibody immunostained the basal and mainly suprabasal keratinocytes. Small perivascular clusters of infiltrating mononuclear cells were positive; scattered spindle fibroblast-like cells were immunostained in superficial and deep dermal layers. The serum concentrations of MIF in patients with dSSc (mean (SD) 10705.6 (9311) pg/ml) were significantly higher than in controls (2157.5 (1288.6) pg/ml; p=0.011); MIF levels from dSSc fibroblast cultures (mean (SD) 1.74 (0.16) ng/2 x 10(5) cells) were also significantly higher than in controls (0.6 (0.2) ng/2 x 10(5) cells; p=0.008).
CONCLUSION: These results suggest that MIF may be involved in the amplifying proinflammatory loop leading to scleroderma tissue remodelling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695161      PMCID: PMC1754538          DOI: 10.1136/ard.62.5.460

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  Alpha-thrombin stimulates expression of macrophage migration inhibitory factor in skin fibroblasts.

Authors:  T Shimizu; A Ohkawara; Y Mizue; J Nishihira
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

Review 2.  Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery.

Authors:  E Lolis
Journal:  Curr Opin Pharmacol       Date:  2001-12       Impact factor: 5.547

3.  Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis.

Authors:  M Leech; C Metz; L Santos; T Peng; S R Holdsworth; R Bucala; E F Morand
Journal:  Arthritis Rheum       Date:  1998-05

4.  Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth.

Authors:  N Takahashi; J Nishihira; Y Sato; M Kondo; H Ogawa; T Ohshima; Y Une; S Todo
Journal:  Mol Med       Date:  1998-11       Impact factor: 6.354

5.  Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression.

Authors:  M Galindo; B Santiago; M Rivero; J Rullas; J Alcami; J L Pablos
Journal:  Arthritis Rheum       Date:  2001-06

6.  Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor.

Authors:  A V Sampey; P H Hall; R A Mitchell; C N Metz; E F Morand
Journal:  Arthritis Rheum       Date:  2001-06

7.  Macrophage migration inhibitory factor in the human endometrium: expression and localization during the menstrual cycle and early pregnancy.

Authors:  F Arcuri; C Ricci; F Ietta; M Cintorino; S A Tripodi; I Cetin; E Garzia; F Schatz; P Klemi; R Santopietro; L Paulesu
Journal:  Biol Reprod       Date:  2001-04       Impact factor: 4.285

8.  Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts.

Authors:  R Abe; T Shimizu; A Ohkawara; J Nishihira
Journal:  Biochim Biophys Acta       Date:  2000-01-03

9.  Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis.

Authors:  Cristina Meazza; Paola Travaglino; Patrizia Pignatti; Silvia Magni-Manzoni; Angelo Ravelli; Alberto Martini; Fabrizio De Benedetti
Journal:  Arthritis Rheum       Date:  2002-01

10.  Evidence for a role of macrophage migration inhibitory factor in psoriatic skin disease.

Authors:  M Steinhoff; A Meinhardt; A Steinhoff; D Gemsa; R Bucala; M Bacher
Journal:  Br J Dermatol       Date:  1999-12       Impact factor: 9.302

View more
  12 in total

1.  The Immunogenetics of Systemic Sclerosis.

Authors:  Begüm Ünlü; Ümit Türsen; Zeynab Rajabi; Navid Jabalameli; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Up-regulated macrophage migration inhibitory factor protects apoptosis of dermal fibroblasts in patients with systemic sclerosis.

Authors:  J-Y Kim; S-K Kwok; K-H Hur; H-J Kim; N S Kim; S-A Yoo; W-U Kim; C-S Cho
Journal:  Clin Exp Immunol       Date:  2008-03-18       Impact factor: 4.330

3.  Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis.

Authors:  Heidemarie Becker; Peter Willeke; Heiko Schotte; Wolfram Domschke; Markus Gaubitz
Journal:  Clin Rheumatol       Date:  2008-07-11       Impact factor: 2.980

4.  Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases.

Authors:  Tsuyoshi Kasama; Kumiko Ohtsuka; Michihito Sato; Ryo Takahashi; Kuninobu Wakabayashi; Kazuo Kobayashi
Journal:  Arthritis       Date:  2010-12-26

5.  Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris.

Authors:  Lei Ma; Hai-Bo Xue; Xiu-Hao Guan; Chun-Mei Shu; Yu-Jie Zhang; Jun-Hua Zhang; Rong-Zhen An
Journal:  Braz J Med Biol Res       Date:  2013-05       Impact factor: 2.590

6.  The role of macrophage migration inhibitory factor in mast cell-stimulated fibroblast proliferation and collagen production.

Authors:  Gu Ningyan; Yao Xu; Shi Hongfei; Chen Jingjing; Chen Min
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

7.  Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis.

Authors:  Hirohito Kanemitsu; Mizuho Matsunawa; Kuninobu Wakabayashi; Michihito Sato; Ryo Takahashi; Tsuyoshi Odai; Takeo Isozaki; Nobuyuki Yajima; Yusuke Miwa; Tsuyoshi Kasama
Journal:  Open Access Rheumatol       Date:  2009-03-13

8.  Analysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosis.

Authors:  Fabien B Vincent; Emily Lin; Joanne Sahhar; Gene-Siew Ngian; Rangi Kandane-Rathnayake; Rachel Mende; Alberta Y Hoi; Eric F Morand; Tali Lang; James Harris
Journal:  Clin Transl Immunology       Date:  2018-12-06

Review 9.  The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review.

Authors:  Wen-Tao Ma; Fei Gao; Kui Gu; De-Kun Chen
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

Review 10.  Macrophage migration inhibitory factor (MIF) in the development and progression of pulmonary arterial hypertension.

Authors:  Mohamed Ahmed; Edmund Miller
Journal:  Glob Cardiol Sci Pract       Date:  2018-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.